Medical Care
Global Live Biotherapeutic Products Market Research Report 2025
- Apr 07, 25
- ID: 167710
- Pages: 73
- Figures: 72
- Views: 43
The global market for Live Biotherapeutic Products was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Live Biotherapeutic Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Biotherapeutic Products.
The Live Biotherapeutic Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Live Biotherapeutic Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Biotherapeutic Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Segment by Type
Solids
Oral Liquids
Injectables
Others
Segment by Application
Autoimmune Disease
Digestive System Diseases
Infectious Disease
Metabolic Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Live Biotherapeutic Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Live Biotherapeutic Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Live Biotherapeutic Products.
The Live Biotherapeutic Products market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Live Biotherapeutic Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Live Biotherapeutic Products companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Capsugel
Jeneil Biotech
UAS Labs
Biose
Cerbios-Pharma
Inpac Probiotics
NIZO
Winclove Probiotics
BJP Laboratories
Segment by Type
Solids
Oral Liquids
Injectables
Others
Segment by Application
Autoimmune Disease
Digestive System Diseases
Infectious Disease
Metabolic Disease
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Live Biotherapeutic Products company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Live Biotherapeutic Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solids
1.2.3 Oral Liquids
1.2.4 Injectables
1.2.5 Others
1.3 Market by Application
1.3.1 Global Live Biotherapeutic Products Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Autoimmune Disease
1.3.3 Digestive System Diseases
1.3.4 Infectious Disease
1.3.5 Metabolic Disease
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Live Biotherapeutic Products Market Perspective (2020-2031)
2.2 Global Live Biotherapeutic Products Growth Trends by Region
2.2.1 Global Live Biotherapeutic Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Live Biotherapeutic Products Historic Market Size by Region (2020-2025)
2.2.3 Live Biotherapeutic Products Forecasted Market Size by Region (2026-2031)
2.3 Live Biotherapeutic Products Market Dynamics
2.3.1 Live Biotherapeutic Products Industry Trends
2.3.2 Live Biotherapeutic Products Market Drivers
2.3.3 Live Biotherapeutic Products Market Challenges
2.3.4 Live Biotherapeutic Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Live Biotherapeutic Products Players by Revenue
3.1.1 Global Top Live Biotherapeutic Products Players by Revenue (2020-2025)
3.1.2 Global Live Biotherapeutic Products Revenue Market Share by Players (2020-2025)
3.2 Global Live Biotherapeutic Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Live Biotherapeutic Products Revenue
3.4 Global Live Biotherapeutic Products Market Concentration Ratio
3.4.1 Global Live Biotherapeutic Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Live Biotherapeutic Products Revenue in 2024
3.5 Global Key Players of Live Biotherapeutic Products Head office and Area Served
3.6 Global Key Players of Live Biotherapeutic Products, Product and Application
3.7 Global Key Players of Live Biotherapeutic Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Live Biotherapeutic Products Breakdown Data by Type
4.1 Global Live Biotherapeutic Products Historic Market Size by Type (2020-2025)
4.2 Global Live Biotherapeutic Products Forecasted Market Size by Type (2026-2031)
5 Live Biotherapeutic Products Breakdown Data by Application
5.1 Global Live Biotherapeutic Products Historic Market Size by Application (2020-2025)
5.2 Global Live Biotherapeutic Products Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Live Biotherapeutic Products Market Size (2020-2031)
6.2 North America Live Biotherapeutic Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Live Biotherapeutic Products Market Size by Country (2020-2025)
6.4 North America Live Biotherapeutic Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Live Biotherapeutic Products Market Size (2020-2031)
7.2 Europe Live Biotherapeutic Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Live Biotherapeutic Products Market Size by Country (2020-2025)
7.4 Europe Live Biotherapeutic Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Live Biotherapeutic Products Market Size (2020-2031)
8.2 Asia-Pacific Live Biotherapeutic Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Live Biotherapeutic Products Market Size by Region (2020-2025)
8.4 Asia-Pacific Live Biotherapeutic Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Live Biotherapeutic Products Market Size (2020-2031)
9.2 Latin America Live Biotherapeutic Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Live Biotherapeutic Products Market Size by Country (2020-2025)
9.4 Latin America Live Biotherapeutic Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Live Biotherapeutic Products Market Size (2020-2031)
10.2 Middle East & Africa Live Biotherapeutic Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Live Biotherapeutic Products Market Size by Country (2020-2025)
10.4 Middle East & Africa Live Biotherapeutic Products Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Capsugel
11.1.1 Capsugel Company Details
11.1.2 Capsugel Business Overview
11.1.3 Capsugel Live Biotherapeutic Products Introduction
11.1.4 Capsugel Revenue in Live Biotherapeutic Products Business (2020-2025)
11.1.5 Capsugel Recent Development
11.2 Jeneil Biotech
11.2.1 Jeneil Biotech Company Details
11.2.2 Jeneil Biotech Business Overview
11.2.3 Jeneil Biotech Live Biotherapeutic Products Introduction
11.2.4 Jeneil Biotech Revenue in Live Biotherapeutic Products Business (2020-2025)
11.2.5 Jeneil Biotech Recent Development
11.3 UAS Labs
11.3.1 UAS Labs Company Details
11.3.2 UAS Labs Business Overview
11.3.3 UAS Labs Live Biotherapeutic Products Introduction
11.3.4 UAS Labs Revenue in Live Biotherapeutic Products Business (2020-2025)
11.3.5 UAS Labs Recent Development
11.4 Biose
11.4.1 Biose Company Details
11.4.2 Biose Business Overview
11.4.3 Biose Live Biotherapeutic Products Introduction
11.4.4 Biose Revenue in Live Biotherapeutic Products Business (2020-2025)
11.4.5 Biose Recent Development
11.5 Cerbios-Pharma
11.5.1 Cerbios-Pharma Company Details
11.5.2 Cerbios-Pharma Business Overview
11.5.3 Cerbios-Pharma Live Biotherapeutic Products Introduction
11.5.4 Cerbios-Pharma Revenue in Live Biotherapeutic Products Business (2020-2025)
11.5.5 Cerbios-Pharma Recent Development
11.6 Inpac Probiotics
11.6.1 Inpac Probiotics Company Details
11.6.2 Inpac Probiotics Business Overview
11.6.3 Inpac Probiotics Live Biotherapeutic Products Introduction
11.6.4 Inpac Probiotics Revenue in Live Biotherapeutic Products Business (2020-2025)
11.6.5 Inpac Probiotics Recent Development
11.7 NIZO
11.7.1 NIZO Company Details
11.7.2 NIZO Business Overview
11.7.3 NIZO Live Biotherapeutic Products Introduction
11.7.4 NIZO Revenue in Live Biotherapeutic Products Business (2020-2025)
11.7.5 NIZO Recent Development
11.8 Winclove Probiotics
11.8.1 Winclove Probiotics Company Details
11.8.2 Winclove Probiotics Business Overview
11.8.3 Winclove Probiotics Live Biotherapeutic Products Introduction
11.8.4 Winclove Probiotics Revenue in Live Biotherapeutic Products Business (2020-2025)
11.8.5 Winclove Probiotics Recent Development
11.9 BJP Laboratories
11.9.1 BJP Laboratories Company Details
11.9.2 BJP Laboratories Business Overview
11.9.3 BJP Laboratories Live Biotherapeutic Products Introduction
11.9.4 BJP Laboratories Revenue in Live Biotherapeutic Products Business (2020-2025)
11.9.5 BJP Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Live Biotherapeutic Products Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Solids
1.2.3 Oral Liquids
1.2.4 Injectables
1.2.5 Others
1.3 Market by Application
1.3.1 Global Live Biotherapeutic Products Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Autoimmune Disease
1.3.3 Digestive System Diseases
1.3.4 Infectious Disease
1.3.5 Metabolic Disease
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Live Biotherapeutic Products Market Perspective (2020-2031)
2.2 Global Live Biotherapeutic Products Growth Trends by Region
2.2.1 Global Live Biotherapeutic Products Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Live Biotherapeutic Products Historic Market Size by Region (2020-2025)
2.2.3 Live Biotherapeutic Products Forecasted Market Size by Region (2026-2031)
2.3 Live Biotherapeutic Products Market Dynamics
2.3.1 Live Biotherapeutic Products Industry Trends
2.3.2 Live Biotherapeutic Products Market Drivers
2.3.3 Live Biotherapeutic Products Market Challenges
2.3.4 Live Biotherapeutic Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Live Biotherapeutic Products Players by Revenue
3.1.1 Global Top Live Biotherapeutic Products Players by Revenue (2020-2025)
3.1.2 Global Live Biotherapeutic Products Revenue Market Share by Players (2020-2025)
3.2 Global Live Biotherapeutic Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Live Biotherapeutic Products Revenue
3.4 Global Live Biotherapeutic Products Market Concentration Ratio
3.4.1 Global Live Biotherapeutic Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Live Biotherapeutic Products Revenue in 2024
3.5 Global Key Players of Live Biotherapeutic Products Head office and Area Served
3.6 Global Key Players of Live Biotherapeutic Products, Product and Application
3.7 Global Key Players of Live Biotherapeutic Products, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Live Biotherapeutic Products Breakdown Data by Type
4.1 Global Live Biotherapeutic Products Historic Market Size by Type (2020-2025)
4.2 Global Live Biotherapeutic Products Forecasted Market Size by Type (2026-2031)
5 Live Biotherapeutic Products Breakdown Data by Application
5.1 Global Live Biotherapeutic Products Historic Market Size by Application (2020-2025)
5.2 Global Live Biotherapeutic Products Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Live Biotherapeutic Products Market Size (2020-2031)
6.2 North America Live Biotherapeutic Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Live Biotherapeutic Products Market Size by Country (2020-2025)
6.4 North America Live Biotherapeutic Products Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Live Biotherapeutic Products Market Size (2020-2031)
7.2 Europe Live Biotherapeutic Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Live Biotherapeutic Products Market Size by Country (2020-2025)
7.4 Europe Live Biotherapeutic Products Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Live Biotherapeutic Products Market Size (2020-2031)
8.2 Asia-Pacific Live Biotherapeutic Products Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Live Biotherapeutic Products Market Size by Region (2020-2025)
8.4 Asia-Pacific Live Biotherapeutic Products Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Live Biotherapeutic Products Market Size (2020-2031)
9.2 Latin America Live Biotherapeutic Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Live Biotherapeutic Products Market Size by Country (2020-2025)
9.4 Latin America Live Biotherapeutic Products Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Live Biotherapeutic Products Market Size (2020-2031)
10.2 Middle East & Africa Live Biotherapeutic Products Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Live Biotherapeutic Products Market Size by Country (2020-2025)
10.4 Middle East & Africa Live Biotherapeutic Products Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Capsugel
11.1.1 Capsugel Company Details
11.1.2 Capsugel Business Overview
11.1.3 Capsugel Live Biotherapeutic Products Introduction
11.1.4 Capsugel Revenue in Live Biotherapeutic Products Business (2020-2025)
11.1.5 Capsugel Recent Development
11.2 Jeneil Biotech
11.2.1 Jeneil Biotech Company Details
11.2.2 Jeneil Biotech Business Overview
11.2.3 Jeneil Biotech Live Biotherapeutic Products Introduction
11.2.4 Jeneil Biotech Revenue in Live Biotherapeutic Products Business (2020-2025)
11.2.5 Jeneil Biotech Recent Development
11.3 UAS Labs
11.3.1 UAS Labs Company Details
11.3.2 UAS Labs Business Overview
11.3.3 UAS Labs Live Biotherapeutic Products Introduction
11.3.4 UAS Labs Revenue in Live Biotherapeutic Products Business (2020-2025)
11.3.5 UAS Labs Recent Development
11.4 Biose
11.4.1 Biose Company Details
11.4.2 Biose Business Overview
11.4.3 Biose Live Biotherapeutic Products Introduction
11.4.4 Biose Revenue in Live Biotherapeutic Products Business (2020-2025)
11.4.5 Biose Recent Development
11.5 Cerbios-Pharma
11.5.1 Cerbios-Pharma Company Details
11.5.2 Cerbios-Pharma Business Overview
11.5.3 Cerbios-Pharma Live Biotherapeutic Products Introduction
11.5.4 Cerbios-Pharma Revenue in Live Biotherapeutic Products Business (2020-2025)
11.5.5 Cerbios-Pharma Recent Development
11.6 Inpac Probiotics
11.6.1 Inpac Probiotics Company Details
11.6.2 Inpac Probiotics Business Overview
11.6.3 Inpac Probiotics Live Biotherapeutic Products Introduction
11.6.4 Inpac Probiotics Revenue in Live Biotherapeutic Products Business (2020-2025)
11.6.5 Inpac Probiotics Recent Development
11.7 NIZO
11.7.1 NIZO Company Details
11.7.2 NIZO Business Overview
11.7.3 NIZO Live Biotherapeutic Products Introduction
11.7.4 NIZO Revenue in Live Biotherapeutic Products Business (2020-2025)
11.7.5 NIZO Recent Development
11.8 Winclove Probiotics
11.8.1 Winclove Probiotics Company Details
11.8.2 Winclove Probiotics Business Overview
11.8.3 Winclove Probiotics Live Biotherapeutic Products Introduction
11.8.4 Winclove Probiotics Revenue in Live Biotherapeutic Products Business (2020-2025)
11.8.5 Winclove Probiotics Recent Development
11.9 BJP Laboratories
11.9.1 BJP Laboratories Company Details
11.9.2 BJP Laboratories Business Overview
11.9.3 BJP Laboratories Live Biotherapeutic Products Introduction
11.9.4 BJP Laboratories Revenue in Live Biotherapeutic Products Business (2020-2025)
11.9.5 BJP Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Live Biotherapeutic Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Solids
Table 3. Key Players of Oral Liquids
Table 4. Key Players of Injectables
Table 5. Key Players of Others
Table 6. Global Live Biotherapeutic Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Live Biotherapeutic Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Live Biotherapeutic Products Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Live Biotherapeutic Products Market Share by Region (2020-2025)
Table 10. Global Live Biotherapeutic Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Live Biotherapeutic Products Market Share by Region (2026-2031)
Table 12. Live Biotherapeutic Products Market Trends
Table 13. Live Biotherapeutic Products Market Drivers
Table 14. Live Biotherapeutic Products Market Challenges
Table 15. Live Biotherapeutic Products Market Restraints
Table 16. Global Live Biotherapeutic Products Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Live Biotherapeutic Products Market Share by Players (2020-2025)
Table 18. Global Top Live Biotherapeutic Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products as of 2024)
Table 19. Ranking of Global Top Live Biotherapeutic Products Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Live Biotherapeutic Products Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Live Biotherapeutic Products, Headquarters and Area Served
Table 22. Global Key Players of Live Biotherapeutic Products, Product and Application
Table 23. Global Key Players of Live Biotherapeutic Products, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Live Biotherapeutic Products Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Live Biotherapeutic Products Revenue Market Share by Type (2020-2025)
Table 27. Global Live Biotherapeutic Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Live Biotherapeutic Products Revenue Market Share by Type (2026-2031)
Table 29. Global Live Biotherapeutic Products Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Live Biotherapeutic Products Revenue Market Share by Application (2020-2025)
Table 31. Global Live Biotherapeutic Products Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Live Biotherapeutic Products Revenue Market Share by Application (2026-2031)
Table 33. North America Live Biotherapeutic Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Live Biotherapeutic Products Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Live Biotherapeutic Products Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Live Biotherapeutic Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Live Biotherapeutic Products Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Live Biotherapeutic Products Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Live Biotherapeutic Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Live Biotherapeutic Products Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Live Biotherapeutic Products Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Live Biotherapeutic Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Live Biotherapeutic Products Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Live Biotherapeutic Products Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Live Biotherapeutic Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Live Biotherapeutic Products Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Live Biotherapeutic Products Market Size by Country (2026-2031) & (US$ Million)
Table 48. Capsugel Company Details
Table 49. Capsugel Business Overview
Table 50. Capsugel Live Biotherapeutic Products Product
Table 51. Capsugel Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 52. Capsugel Recent Development
Table 53. Jeneil Biotech Company Details
Table 54. Jeneil Biotech Business Overview
Table 55. Jeneil Biotech Live Biotherapeutic Products Product
Table 56. Jeneil Biotech Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 57. Jeneil Biotech Recent Development
Table 58. UAS Labs Company Details
Table 59. UAS Labs Business Overview
Table 60. UAS Labs Live Biotherapeutic Products Product
Table 61. UAS Labs Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 62. UAS Labs Recent Development
Table 63. Biose Company Details
Table 64. Biose Business Overview
Table 65. Biose Live Biotherapeutic Products Product
Table 66. Biose Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 67. Biose Recent Development
Table 68. Cerbios-Pharma Company Details
Table 69. Cerbios-Pharma Business Overview
Table 70. Cerbios-Pharma Live Biotherapeutic Products Product
Table 71. Cerbios-Pharma Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 72. Cerbios-Pharma Recent Development
Table 73. Inpac Probiotics Company Details
Table 74. Inpac Probiotics Business Overview
Table 75. Inpac Probiotics Live Biotherapeutic Products Product
Table 76. Inpac Probiotics Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 77. Inpac Probiotics Recent Development
Table 78. NIZO Company Details
Table 79. NIZO Business Overview
Table 80. NIZO Live Biotherapeutic Products Product
Table 81. NIZO Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 82. NIZO Recent Development
Table 83. Winclove Probiotics Company Details
Table 84. Winclove Probiotics Business Overview
Table 85. Winclove Probiotics Live Biotherapeutic Products Product
Table 86. Winclove Probiotics Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 87. Winclove Probiotics Recent Development
Table 88. BJP Laboratories Company Details
Table 89. BJP Laboratories Business Overview
Table 90. BJP Laboratories Live Biotherapeutic Products Product
Table 91. BJP Laboratories Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 92. BJP Laboratories Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Live Biotherapeutic Products Picture
Figure 2. Global Live Biotherapeutic Products Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Live Biotherapeutic Products Market Share by Type: 2024 VS 2031
Figure 4. Solids Features
Figure 5. Oral Liquids Features
Figure 6. Injectables Features
Figure 7. Others Features
Figure 8. Global Live Biotherapeutic Products Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Live Biotherapeutic Products Market Share by Application: 2024 VS 2031
Figure 10. Autoimmune Disease Case Studies
Figure 11. Digestive System Diseases Case Studies
Figure 12. Infectious Disease Case Studies
Figure 13. Metabolic Disease Case Studies
Figure 14. Others Case Studies
Figure 15. Live Biotherapeutic Products Report Years Considered
Figure 16. Global Live Biotherapeutic Products Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Live Biotherapeutic Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Live Biotherapeutic Products Market Share by Region: 2024 VS 2031
Figure 19. Global Live Biotherapeutic Products Market Share by Players in 2024
Figure 20. Global Top Live Biotherapeutic Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Live Biotherapeutic Products Revenue in 2024
Figure 22. North America Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Live Biotherapeutic Products Market Share by Country (2020-2031)
Figure 24. United States Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Live Biotherapeutic Products Market Share by Country (2020-2031)
Figure 28. Germany Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Live Biotherapeutic Products Market Share by Region (2020-2031)
Figure 36. China Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Live Biotherapeutic Products Market Share by Country (2020-2031)
Figure 44. Mexico Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Live Biotherapeutic Products Market Share by Country (2020-2031)
Figure 48. Turkey Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Capsugel Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 52. Jeneil Biotech Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 53. UAS Labs Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 54. Biose Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 55. Cerbios-Pharma Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 56. Inpac Probiotics Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 57. NIZO Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 58. Winclove Probiotics Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 59. BJP Laboratories Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Live Biotherapeutic Products Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Solids
Table 3. Key Players of Oral Liquids
Table 4. Key Players of Injectables
Table 5. Key Players of Others
Table 6. Global Live Biotherapeutic Products Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Live Biotherapeutic Products Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Live Biotherapeutic Products Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Live Biotherapeutic Products Market Share by Region (2020-2025)
Table 10. Global Live Biotherapeutic Products Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Live Biotherapeutic Products Market Share by Region (2026-2031)
Table 12. Live Biotherapeutic Products Market Trends
Table 13. Live Biotherapeutic Products Market Drivers
Table 14. Live Biotherapeutic Products Market Challenges
Table 15. Live Biotherapeutic Products Market Restraints
Table 16. Global Live Biotherapeutic Products Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Live Biotherapeutic Products Market Share by Players (2020-2025)
Table 18. Global Top Live Biotherapeutic Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products as of 2024)
Table 19. Ranking of Global Top Live Biotherapeutic Products Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Live Biotherapeutic Products Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Live Biotherapeutic Products, Headquarters and Area Served
Table 22. Global Key Players of Live Biotherapeutic Products, Product and Application
Table 23. Global Key Players of Live Biotherapeutic Products, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Live Biotherapeutic Products Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Live Biotherapeutic Products Revenue Market Share by Type (2020-2025)
Table 27. Global Live Biotherapeutic Products Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Live Biotherapeutic Products Revenue Market Share by Type (2026-2031)
Table 29. Global Live Biotherapeutic Products Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Live Biotherapeutic Products Revenue Market Share by Application (2020-2025)
Table 31. Global Live Biotherapeutic Products Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Live Biotherapeutic Products Revenue Market Share by Application (2026-2031)
Table 33. North America Live Biotherapeutic Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Live Biotherapeutic Products Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Live Biotherapeutic Products Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Live Biotherapeutic Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Live Biotherapeutic Products Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Live Biotherapeutic Products Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Live Biotherapeutic Products Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Live Biotherapeutic Products Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Live Biotherapeutic Products Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Live Biotherapeutic Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Live Biotherapeutic Products Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Live Biotherapeutic Products Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Live Biotherapeutic Products Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Live Biotherapeutic Products Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Live Biotherapeutic Products Market Size by Country (2026-2031) & (US$ Million)
Table 48. Capsugel Company Details
Table 49. Capsugel Business Overview
Table 50. Capsugel Live Biotherapeutic Products Product
Table 51. Capsugel Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 52. Capsugel Recent Development
Table 53. Jeneil Biotech Company Details
Table 54. Jeneil Biotech Business Overview
Table 55. Jeneil Biotech Live Biotherapeutic Products Product
Table 56. Jeneil Biotech Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 57. Jeneil Biotech Recent Development
Table 58. UAS Labs Company Details
Table 59. UAS Labs Business Overview
Table 60. UAS Labs Live Biotherapeutic Products Product
Table 61. UAS Labs Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 62. UAS Labs Recent Development
Table 63. Biose Company Details
Table 64. Biose Business Overview
Table 65. Biose Live Biotherapeutic Products Product
Table 66. Biose Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 67. Biose Recent Development
Table 68. Cerbios-Pharma Company Details
Table 69. Cerbios-Pharma Business Overview
Table 70. Cerbios-Pharma Live Biotherapeutic Products Product
Table 71. Cerbios-Pharma Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 72. Cerbios-Pharma Recent Development
Table 73. Inpac Probiotics Company Details
Table 74. Inpac Probiotics Business Overview
Table 75. Inpac Probiotics Live Biotherapeutic Products Product
Table 76. Inpac Probiotics Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 77. Inpac Probiotics Recent Development
Table 78. NIZO Company Details
Table 79. NIZO Business Overview
Table 80. NIZO Live Biotherapeutic Products Product
Table 81. NIZO Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 82. NIZO Recent Development
Table 83. Winclove Probiotics Company Details
Table 84. Winclove Probiotics Business Overview
Table 85. Winclove Probiotics Live Biotherapeutic Products Product
Table 86. Winclove Probiotics Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 87. Winclove Probiotics Recent Development
Table 88. BJP Laboratories Company Details
Table 89. BJP Laboratories Business Overview
Table 90. BJP Laboratories Live Biotherapeutic Products Product
Table 91. BJP Laboratories Revenue in Live Biotherapeutic Products Business (2020-2025) & (US$ Million)
Table 92. BJP Laboratories Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
Table 96. Authors List of This Report
List of Figures
Figure 1. Live Biotherapeutic Products Picture
Figure 2. Global Live Biotherapeutic Products Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Live Biotherapeutic Products Market Share by Type: 2024 VS 2031
Figure 4. Solids Features
Figure 5. Oral Liquids Features
Figure 6. Injectables Features
Figure 7. Others Features
Figure 8. Global Live Biotherapeutic Products Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Live Biotherapeutic Products Market Share by Application: 2024 VS 2031
Figure 10. Autoimmune Disease Case Studies
Figure 11. Digestive System Diseases Case Studies
Figure 12. Infectious Disease Case Studies
Figure 13. Metabolic Disease Case Studies
Figure 14. Others Case Studies
Figure 15. Live Biotherapeutic Products Report Years Considered
Figure 16. Global Live Biotherapeutic Products Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Live Biotherapeutic Products Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Live Biotherapeutic Products Market Share by Region: 2024 VS 2031
Figure 19. Global Live Biotherapeutic Products Market Share by Players in 2024
Figure 20. Global Top Live Biotherapeutic Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Live Biotherapeutic Products as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Live Biotherapeutic Products Revenue in 2024
Figure 22. North America Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Live Biotherapeutic Products Market Share by Country (2020-2031)
Figure 24. United States Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Live Biotherapeutic Products Market Share by Country (2020-2031)
Figure 28. Germany Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Live Biotherapeutic Products Market Share by Region (2020-2031)
Figure 36. China Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Live Biotherapeutic Products Market Share by Country (2020-2031)
Figure 44. Mexico Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Live Biotherapeutic Products Market Share by Country (2020-2031)
Figure 48. Turkey Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Live Biotherapeutic Products Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Capsugel Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 52. Jeneil Biotech Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 53. UAS Labs Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 54. Biose Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 55. Cerbios-Pharma Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 56. Inpac Probiotics Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 57. NIZO Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 58. Winclove Probiotics Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 59. BJP Laboratories Revenue Growth Rate in Live Biotherapeutic Products Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232